We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
by Deep Bio
AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target
Jennifer Van Eyk
Remote self-sampling may improve diagnosis and prognosis while reducing costs, but numerous factors must be considered for appropriate implementation
Case of the Month is back for November – but can you diagnose this 1.5 cm polypoid mass shown by ureteroscopy?
An analysis of 1,000 Swedish genomes reveals greater heterogeneity and shows why the human reference genome needs updating
A new kind of deep learning model uses nonlinear information to draw new associations between genes and diseases
Pharmacogenomic testing can only improve patient care if it’s clinically validated, judiciously applied, and easily understood by healthcare providers
Take October's case and tell us which syndrome typically involves pancreatic tumors of this type
New research shows that genome-wide testing of DNA methylation can diagnose previously unsolved cases of neurodevelopmental and congenital anomalies
Simple, accurate, and reproducible methods can help with treatment selection and resistance detection via liquid biopsy
Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.